Cargando…

Heterogeneous bone marrow uptake on interim (18)F-fluorodeoxyglucose positron emission tomography for lymphoma mimicking disease progression: a case report

INTRODUCTION: The use of (18)F-fluorodeoxyglucose positron emission tomography ((18)F-FDG PET) scanning for baseline staging and assessment of treatment response for higher grade lymphomas is considered to be the standard of care. Evaluation of lymphomatous bone marrow infiltration on (18)F-FDG PET...

Descripción completa

Detalles Bibliográficos
Autores principales: Cherk, Martin H, Patil, Sushrut, Beech, Paul, Kalff, Victor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4228820/
https://www.ncbi.nlm.nih.gov/pubmed/25377897
http://dx.doi.org/10.1186/1752-1947-8-362
_version_ 1782344046898839552
author Cherk, Martin H
Patil, Sushrut
Beech, Paul
Kalff, Victor
author_facet Cherk, Martin H
Patil, Sushrut
Beech, Paul
Kalff, Victor
author_sort Cherk, Martin H
collection PubMed
description INTRODUCTION: The use of (18)F-fluorodeoxyglucose positron emission tomography ((18)F-FDG PET) scanning for baseline staging and assessment of treatment response for higher grade lymphomas is considered to be the standard of care. Evaluation of lymphomatous bone marrow infiltration on (18)F-FDG PET can usually distinguish between normal regenerating marrow following chemotherapy by a characteristic pattern of uptake. CASE PRESENTATION: Here we report the case of a 51-year-old Caucasian woman with mixed low- and high-grade lymphoma with biopsy confirmed marrow infiltration. An interim post-three cycle chemotherapy (18)F-FDG PET scan revealed apparent progression of marrow disease. Subsequent investigations were performed including bone marrow biopsies, repeat (18)F-FDG PET scanning and a white cell scan. These revealed the interim (18)F-FDG PET scan appearance was due to a highly unusual pattern of scattered islands of regenerating normal marrow, rather than progressive lymphoma. CONCLUSIONS: Our case report highlights that apparent severe bone marrow abnormalities on (18)F-FDG PET scans in lymphoma patients treated with chemotherapy are not always due to disease. Clinicians should retain a high index of suspicion for benign causes when (18)F-FDG PET scan results appear incongruent with clinical response.
format Online
Article
Text
id pubmed-4228820
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42288202014-11-12 Heterogeneous bone marrow uptake on interim (18)F-fluorodeoxyglucose positron emission tomography for lymphoma mimicking disease progression: a case report Cherk, Martin H Patil, Sushrut Beech, Paul Kalff, Victor J Med Case Rep Case Report INTRODUCTION: The use of (18)F-fluorodeoxyglucose positron emission tomography ((18)F-FDG PET) scanning for baseline staging and assessment of treatment response for higher grade lymphomas is considered to be the standard of care. Evaluation of lymphomatous bone marrow infiltration on (18)F-FDG PET can usually distinguish between normal regenerating marrow following chemotherapy by a characteristic pattern of uptake. CASE PRESENTATION: Here we report the case of a 51-year-old Caucasian woman with mixed low- and high-grade lymphoma with biopsy confirmed marrow infiltration. An interim post-three cycle chemotherapy (18)F-FDG PET scan revealed apparent progression of marrow disease. Subsequent investigations were performed including bone marrow biopsies, repeat (18)F-FDG PET scanning and a white cell scan. These revealed the interim (18)F-FDG PET scan appearance was due to a highly unusual pattern of scattered islands of regenerating normal marrow, rather than progressive lymphoma. CONCLUSIONS: Our case report highlights that apparent severe bone marrow abnormalities on (18)F-FDG PET scans in lymphoma patients treated with chemotherapy are not always due to disease. Clinicians should retain a high index of suspicion for benign causes when (18)F-FDG PET scan results appear incongruent with clinical response. BioMed Central 2014-11-07 /pmc/articles/PMC4228820/ /pubmed/25377897 http://dx.doi.org/10.1186/1752-1947-8-362 Text en Copyright © 2014 Cherk et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Case Report
Cherk, Martin H
Patil, Sushrut
Beech, Paul
Kalff, Victor
Heterogeneous bone marrow uptake on interim (18)F-fluorodeoxyglucose positron emission tomography for lymphoma mimicking disease progression: a case report
title Heterogeneous bone marrow uptake on interim (18)F-fluorodeoxyglucose positron emission tomography for lymphoma mimicking disease progression: a case report
title_full Heterogeneous bone marrow uptake on interim (18)F-fluorodeoxyglucose positron emission tomography for lymphoma mimicking disease progression: a case report
title_fullStr Heterogeneous bone marrow uptake on interim (18)F-fluorodeoxyglucose positron emission tomography for lymphoma mimicking disease progression: a case report
title_full_unstemmed Heterogeneous bone marrow uptake on interim (18)F-fluorodeoxyglucose positron emission tomography for lymphoma mimicking disease progression: a case report
title_short Heterogeneous bone marrow uptake on interim (18)F-fluorodeoxyglucose positron emission tomography for lymphoma mimicking disease progression: a case report
title_sort heterogeneous bone marrow uptake on interim (18)f-fluorodeoxyglucose positron emission tomography for lymphoma mimicking disease progression: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4228820/
https://www.ncbi.nlm.nih.gov/pubmed/25377897
http://dx.doi.org/10.1186/1752-1947-8-362
work_keys_str_mv AT cherkmartinh heterogeneousbonemarrowuptakeoninterim18ffluorodeoxyglucosepositronemissiontomographyforlymphomamimickingdiseaseprogressionacasereport
AT patilsushrut heterogeneousbonemarrowuptakeoninterim18ffluorodeoxyglucosepositronemissiontomographyforlymphomamimickingdiseaseprogressionacasereport
AT beechpaul heterogeneousbonemarrowuptakeoninterim18ffluorodeoxyglucosepositronemissiontomographyforlymphomamimickingdiseaseprogressionacasereport
AT kalffvictor heterogeneousbonemarrowuptakeoninterim18ffluorodeoxyglucosepositronemissiontomographyforlymphomamimickingdiseaseprogressionacasereport